We left off last week with open compliance questions in the deportation flights litigation, Paul Weiss caving to Donald Trump ...

UBS has no plans to leave Switzerland, the bank's compliance and governance chief Markus Ronner said on Friday amid a debate ...

In April 2024, Entera announced that the Journal of Bone and Mineral Research (JBMR) published EB613 placebo controlled Phase 2 Trial results, highlighting its dual mechanism of action and rapid ...

Coverpla is nearing its 80th anniversary. Alpha Bio will use IFF’s Designed Enzymatic Biomaterials technology to provide high-performance, sustainable alternatives to fossil-based ingredients.